ImmunOs Therapeutics
Developer of novel human immunomodulatory proteins and drugs designed to treat cancer and autoimmune diseases. The company's drugs use proteins that have direct anti-tumour effects that remodel the tu...
Valuation
$18.2M
Market implied
Share Price
N/A
Total Raised
$104.5M
Last Round
N/A